510(k) K182064
K182064 is an FDA 510(k) premarket notification submitted by Baylis Medical Company, Inc. for the device "ExpanSure Transseptal Dilation System". The FDA issued a decision of Substantially Equivalent on March 21, 2019. The device falls under product code DRE (Dilator, Vessel, For Percutaneous Catheterization), a Class II device regulated under 21 CFR 870.1310. Baylis Medical Company, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 21, 2019
- Date Received
- August 1, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dilator, Vessel, For Percutaneous Catheterization
- Device Class
- Class II
- Regulation Number
- 870.1310
- Review Panel
- CV
- Submission Type